No difference was noted between arms at the interim analysis of OS at data maturity. The median OS was 18.9 months versus 18.1 months in olaparib and placebo arms, respectively (HR, 0.91; 95% CI, 0.56-1.46; P = .68).
如果生存率沒提高的的話 ,,,,,
No difference was noted between arms at the interim analysis of OS at data maturity. The median OS was 18.9 months versus 18.1 months in olaparib and placebo arms, respectively (HR, 0.91; 95% CI, 0.56-1.46; P = .68).
如果生存率沒提高的的話 ,,,,,